Tymidinkinas 1 kan användas för tidigt terapisvar vid behandling av bröstcancer

NEXT STORY
OSE Immunotherapeutics Receives a Milestone Payment of €5.4 Million From Bpifrance for SIRPα-Antagonist Monoclonal Antibody BI 765063
PREV STORY
SoldierStrong Donates Its First StrongMind Virtual Reality System to Syracuse Veterans Affairs Medical Center
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cornell Medicine professor and Akelos Inc. scientific founder secures nearly $2M in NIH funding to develop nonaddictive, non-opioid chronic pain treatment

author_avatar
NASDAQ Market News

Medigus Announces Presentation on the MUSE(TM) System During American College of Gastroenterology Annual Scientific Meeting

OMER, Israel, Oct. 19, 2015 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical ...

author_avatar
NASDAQ Market News

Medical Devices Market Size | Is Expected to Gain Momentum by Reaching USD 657.98 Billion by 2028, While Exhibiting a CAGR of 5.4%

author_avatar
NASDAQ Market News